BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 38389426)

  • 1. Proton Therapy in Breast Cancer: A Review of Potential Approaches for Patient Selection.
    Wu XY; Chen M; Cao L; Li M; Chen JY
    Technol Cancer Res Treat; 2024; 23():15330338241234788. PubMed ID: 38389426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiobiological and dosimetric impact of RayStation pencil beam and Monte Carlo algorithms on intensity-modulated proton therapy breast cancer plans.
    Rana S; Greco K; Samuel EJJ; Bennouna J
    J Appl Clin Med Phys; 2019 Aug; 20(8):36-46. PubMed ID: 31343826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Morbidity Reduction With Proton Radiation Therapy for Breast Cancer.
    Braunstein LZ; Cahlon O
    Semin Radiat Oncol; 2018 Apr; 28(2):138-149. PubMed ID: 29735190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Model-based approach for quantitative estimates of skin, heart, and lung toxicity risk for left-side photon and proton irradiation after breast-conserving surgery.
    Tommasino F; Durante M; D'Avino V; Liuzzi R; Conson M; Farace P; Palma G; Schwarz M; Cella L; Pacelli R
    Acta Oncol; 2017 May; 56(5):730-736. PubMed ID: 28281862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential skin morbidity reduction with intensity-modulated proton therapy for breast cancer with nodal involvement.
    Fellin F; Iacco M; D'Avino V; Tommasino F; Farace P; Palma G; Conson M; Giacomelli I; Zucchetti C; Falcinelli L; Amichetti M; Aristei C; Cella L
    Acta Oncol; 2019 Jun; 58(6):934-942. PubMed ID: 30938217
    [No Abstract]   [Full Text] [Related]  

  • 6. Patient selection for proton therapy using Normal Tissue Complication Probability with deep learning dose prediction for oropharyngeal cancer.
    Huet-Dastarac M; Michiels S; Rivas ST; Ozan H; Sterpin E; Lee JA; Barragan-Montero A
    Med Phys; 2023 Oct; 50(10):6201-6214. PubMed ID: 37140481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the NTCP modeling on medical decision to select eligible patient for proton therapy: the usefulness of EUD as an indicator to rank modern photon vs proton treatment plans.
    Chaikh A; Calugaru V; Bondiau PY; Thariat J; Balosso J
    Int J Radiat Biol; 2018 Sep; 94(9):789-797. PubMed ID: 29878849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensity-modulated proton and carbon-ion radiotherapy using a fixed-beam system for locally advanced lung cancer: dosimetric comparison with x-ray radiotherapy and normal tissue complication probability (NTCP) evaluation.
    Ming X; Mao J; Ma N; Chen J; Wang W; Sheng Y; Wu K
    Phys Med Biol; 2024 Jan; 69(1):. PubMed ID: 38064747
    [No Abstract]   [Full Text] [Related]  

  • 9. Model-Based Selection for Proton Therapy in Breast Cancer: Development of the National Indication Protocol for Proton Therapy and First Clinical Experiences.
    Boersma LJ; Sattler MGA; Maduro JH; Bijker N; Essers M; van Gestel CMJ; Klaver YLB; Petoukhova AL; Rodrigues MF; Russell NS; van der Schaaf A; Verhoeven K; van Vulpen M; Schuit E; Langendijk JA
    Clin Oncol (R Coll Radiol); 2022 Apr; 34(4):247-257. PubMed ID: 34996684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technical note: Optimal allocation of limited proton therapy resources using model-based patient selection.
    Papp D; Unkelbach J
    Med Phys; 2022 Aug; 49(8):4980-4987. PubMed ID: 35715935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory gating for proton beam scanning versus photon 3D-CRT for breast cancer radiotherapy.
    Flejmer AM; Edvardsson A; Dohlmar F; Josefsson D; Nilsson M; Witt Nyström P; Dasu A
    Acta Oncol; 2016 May; 55(5):577-83. PubMed ID: 27027913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spot scanning proton arc therapy reduces toxicity in oropharyngeal cancer patients.
    de Jong BA; Battinelli C; Free J; Wagenaar D; Engwall E; Janssens G; Langendijk JA; Korevaar EW; Both S
    Med Phys; 2023 Mar; 50(3):1305-1317. PubMed ID: 36373893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton pencil beam scanning reduces secondary cancer risk in breast cancer patients with internal mammary chain involvement compared to photon radiotherapy.
    Cartechini G; Fracchiolla F; Menegotti L; Scifoni E; La Tessa C; Schwarz M; Farace P; Tommasino F
    Radiat Oncol; 2020 Oct; 15(1):228. PubMed ID: 33008412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility study: spot-scanning proton arc therapy (SPArc) for left-sided whole breast radiotherapy.
    Chang S; Liu G; Zhao L; Dilworth JT; Zheng W; Jawad S; Yan D; Chen P; Stevens C; Kabolizadeh P; Li X; Ding X
    Radiat Oncol; 2020 Oct; 15(1):232. PubMed ID: 33028378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advantage of proton-radiotherapy for pediatric patients and adolescents with Hodgkin's disease.
    Lautenschlaeger S; Iancu G; Flatten V; Baumann K; Thiemer M; Dumke C; Zink K; Hauswald H; Vordermark D; Mauz-Körholz C; Engenhart-Cabillic R; Eberle F
    Radiat Oncol; 2019 Sep; 14(1):157. PubMed ID: 31477141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric comparison between carbon, proton and photon radiation for renal retroperitoneal soft tissue sarcoma recurrence or metastasis after radical nephrectomy.
    Ming X; Wang W; Shahnazi K; Sun J; Zhang Q; Li P; Hong Z; Sheng Y
    Int J Radiat Biol; 2022; 98(2):183-190. PubMed ID: 34802361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin's lymphoma. Assessment of risk of toxicity and secondary cancer induction.
    Scorsetti M; Cozzi L; Navarria P; Fogliata A; Rossi A; Franceschini D; De Rose F; Franzese C; Carlo-Stella C; Santoro A
    Radiat Oncol; 2020 Jan; 15(1):12. PubMed ID: 31931861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Model-Based Approach to Predict Short-Term Toxicity Benefits With Proton Therapy for Oropharyngeal Cancer.
    Rwigema JM; Langendijk JA; Paul van der Laan H; Lukens JN; Swisher-McClure SD; Lin A
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):553-562. PubMed ID: 30625409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Quantitative Clinical Decision-Support Strategy Identifying Which Patients With Oropharyngeal Head and Neck Cancer May Benefit the Most From Proton Radiation Therapy.
    Brodin NP; Kabarriti R; Pankuch M; Schechter CB; Gondi V; Kalnicki S; Guha C; Garg MK; Tomé WA
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):540-552. PubMed ID: 30496877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Quest for Evidence for Proton Therapy: Model-Based Approach and Precision Medicine.
    Widder J; van der Schaaf A; Lambin P; Marijnen CAM; Pignol JP; Rasch CR; Slotman BJ; Verheij M; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):30-36. PubMed ID: 26684410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.